Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Sawai Pharmaceutical patent numbers FY 2012-2016

Number of patents held by Sawai Pharmaceutical Co., Ltd. from fiscal year 2012 to 2016

by Statista Research Department, last edited Sep 24, 2019
Sawai Pharmaceutical patent numbers FY 2012-2016 The statistic illustrates the number of patents held by Sawai Pharmaceutical Co., Ltd. from fiscal year 2012 to 2016 . In fiscal year 2016, the Japanese generics manufacturer Sawai Pharmaceutical held 23 patents, up from nine patents in fiscal 2012.
Show more

Number of patents held by Sawai Pharmaceutical Co., Ltd. from fiscal year 2012 to 2016

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.